Centro Médico Saavedra
Somos un centro médico de investigacion a la vanguardia de la medicina. Contamos con más de 50 estudios clínicos realizados en distintas áreas clínicas.Av. Ruiz Huidobro 4693, C1430 Cdad. Autónoma de Buenos Aires, Argentina
Select an option
I am a doctor
I am a sponsor
Specializations
Cardiologia
Diabetes y Obesidad
Higado Graso
Neumonologia
Infectologia
Ginecologia
Nefrologia
Our team
Medical staff
Martin Horacio Koretzky
María Eugenia Franchi
Alberto Americo Cristino
Gabriel Aballay Soteras
María Belén Umina
Juan Cruz Maguire
Agustín Maguire
Rodolfo Recoaro
Ruben Saurral
Yavu Glenny
Martin Ramirez
Agustina González Pedemonte
Gustavo Bello
Juan Pablo Ponti
Silvina Gabriela Tartara
Gustavo Gabriel Castiello
María de la Paz Surraco
Open studies
Steatohepatitis
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) - ENLIGHTEN-Fibrosis - 89bio, Inc.See more
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis - LIVERAGE - Boehringer IngelheimSee more
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis - LIVERAGE - Cirrosis - Boehringer IngelheimSee more
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - ENLIGHTEN-Cirrhosis - 89bio, Inc.See more
Cardiovascular disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - Eli Lilly and CompanySee more
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease - ZENITH - Alnylam PharmaceuticalsSee more
Cirrhosis
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis - AFFIRM - Gilead SciencesSee more
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis - LIVERAGE - Cirrosis - Boehringer IngelheimSee more
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - ENLIGHTEN-Cirrhosis - 89bio, Inc.See more
Fatty liver/nash
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) - ENLIGHTEN-Fibrosis - 89bio, Inc.See more
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - ENLIGHTEN-Cirrhosis - 89bio, Inc.See more
Renal disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - Eli Lilly and CompanySee more
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) - EASi-KIDNEY™ - Boehringer IngelheimSee more
Cholangitis
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis - AFFIRM - Gilead SciencesSee more
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis - VANTAGE - Mirum Pharmaceuticals, Inc.See more
Obesity
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Arterial hypertension
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease - ZENITH - Alnylam PharmaceuticalsSee more
Fatty Liver
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) - SYNERGY-Outcomes - Eli Lilly and CompanySee more
Hypertriglyceridemia
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis - SHASTA-5 - Arrowhead PharmaceuticalsSee more
Heart failure
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer IngelheimSee more
